Home › Trials › NCT01524276

Registry for evaluating Medtronic products

Medtronic Product Surveillance Registry

Observational Medtronic · NCT01524276

This study is collecting information to see how safe and effective Medtronic products are for patients who are using them.

Quick facts

Study typeObservational
Enrollment100000 (estimated)
SexAll
SponsorMedtronic Industry-sponsored
Locations391 sites (Birmingham, Alabama and 390 other locations)
Trial IDNCT01524276 on ClinicalTrials.gov

What this trial studies

This registry aims to continuously evaluate and report on the safety and effectiveness of Medtronic products that are already on the market. It collects data to support patients, hospitals, clinicians, and regulatory bodies by streamlining the clinical surveillance process. The registry allows for performance assessment of these products with minimal burden on participants. It includes patients who are currently receiving or are intended to receive eligible Medtronic products.

Who should consider this trial

Good fit: Ideal candidates include patients who are receiving or are intended to receive a Medtronic product and can provide consent.

Not a fit: Patients who are inaccessible for follow-up or are enrolled in conflicting studies may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could enhance patient safety and treatment outcomes by providing valuable data on Medtronic products.

How similar studies have performed: Other registries evaluating medical devices have shown success in improving patient outcomes and safety monitoring.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
* Patient has or is intended to receive or be treated with an eligible Medtronic product
* Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

Exclusion Criteria:

* Patient who is, or will be, inaccessible for follow-up
* Patient with exclusion criteria required by local law
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Where this trial is running

Birmingham, Alabama and 390 other locations

+341 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Cardiac Rhythm DisordersUrological DisordersNeurological DisordersCardiovascular DisordersDigestive DisordersIntracranial AneurysmMechanical Circulatory SupportRespiratory Therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.